Diabetes - the Role of Metabolomics in the Discovery of New Mechanisms and Novel Biomarkers (Q57797336)

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Bariatric surgery to treat type 2 diabetes: what is the recent evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Metabolomics in diabetes research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Systems biology: Metabonomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Metabolite profiles and the risk of developing diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Plasma Amino Acid Levels and Insulin Secretion in Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Interplay between lipids and branched-chain amino acids in development of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Pancreatic β-cell death in response to pro-inflammatory cytokines is distinct from genuine apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

A lipidomic screen of palmitate-treated MIN6 β-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Metabolomic analyses reveal profound differences in glycolytic and tricarboxylic acid cycle metabolism in glucose-responsive and -unresponsive clonal β-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor-1{beta} plays a critical role in maintaining glucose-stimulated anaplerosis and insulin release from pancreatic {beta}-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Metabolic regulation in progression to autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Metabolomic biomarkers of impaired glucose tolerance and type 2 diabetes mellitus with a potential for risk stratification in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Effects of a glucokinase activator on hepatic intermediary metabolism: study with 13C-isotopomer-based metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Stable isotope-resolved metabolomics and applications for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

TARDIS-based microbial metabolomics: time and relative differences in systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Selective divalent copper chelation for the treatment of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Metabolomic analysis of rat serum in streptozotocin-induced diabetes and after treatment with oral triethylenetetramine (TETA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Genome-wide association studies with metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Personal omics profiling reveals dynamic molecular and medical phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Personalized medicine in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

Biomarkers for the prediction of type 2 diabetes and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9

An amino acid profile to predict diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12170-012-0282-9